General Information of the Compound
| Compound ID |
CP0503560
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1S,2R)-N-{1-Benzyl-2-hydroxy-3-(S)-[2-(1-benzylpiperidin-4-yl)ethylamino]-propyl}-N'-[(R)-1-(4-fluorophenyl)ethyl]-5-nitroisophthalamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C40H46FN5O5
|
||||||||||||||||||
| Molecular Weight |
695.836
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H](NC(=O)c1cc(cc(c1)[N+]([O-])=O)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCCC1CCN(Cc2ccccc2)CC1)c1ccc(F)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C40H46FN5O5/c1-28(32-12-14-35(41)15-13-32)43-39(48)33-23-34(25-36(24-33)46(50)51)40(49)44-37(22-30-8-4-2-5-9-30)38(47)26-42-19-16-29-17-20-45(21-18-29)27-31-10-6-3-7-11-31/h2-15,23-25,28-29,37-38,42,47H,16-22,26-27H2,1H3,(H,43,48)(H,44,49)/t28-,37+,38-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
FJKQCZAIQHRDHC-KNXHFOKOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound